Literature DB >> 17100889

Natural killer cells in viral infection: more than just killers.

Christopher E Andoniou1, Daniel M Andrews, Mariapia A Degli-Esposti.   

Abstract

Innate immunity was believed originally to serve simply as the first-line defense against infection and malignancy, with adaptive immunity imposing specificity and ensuring that appropriate responses are mounted against chronic or reoccurring challenges. In this model of immunity, innate and adaptive immune responses are sequential, essentially non-overlapping, and interactions between components of each response limited or non-existent. Over the last 5 years, it has become increasingly evident that interactions between elements of the innate and adaptive immune systems are common. Indeed, it is now clear that the generation and maintenance of effective immunity require an extensive array of interactions between multiple components of the immune system. This review discusses recent advances in this area with particular emphasis on the role of natural killer cells in shaping the adaptive immune response to viral infection.

Entities:  

Mesh:

Year:  2006        PMID: 17100889     DOI: 10.1111/j.1600-065X.2006.00465.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  24 in total

Review 1.  Revealing the molecular signatures of host-pathogen interactions.

Authors:  Chiea-Chuen Khor; Martin L Hibberd
Journal:  Genome Biol       Date:  2011-10-19       Impact factor: 13.583

2.  Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection.

Authors:  Q Zheng; Y Y Zhu; J Chen; Y B Ye; J Y Li; Y R Liu; M L Hu; Y C Zheng; J J Jiang
Journal:  Clin Exp Immunol       Date:  2015-04-12       Impact factor: 4.330

Review 3.  Molecular mechanisms of natural killer cell activation in response to cellular stress.

Authors:  C J Chan; M J Smyth; L Martinet
Journal:  Cell Death Differ       Date:  2013-04-12       Impact factor: 15.828

4.  Cytokine-Mediated Activation of NK Cells during Viral Infection.

Authors:  Bailey E Freeman; Hans-Peter Raué; Ann B Hill; Mark K Slifka
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

5.  Comparative analysis of mediastinal fat-associated lymphoid cluster development and lung cellular infiltration in murine autoimmune disease models and the corresponding normal control strains.

Authors:  Yaser Hosny Ali Elewa; Osamu Ichii; Yasuhiro Kon
Journal:  Immunology       Date:  2015-11-16       Impact factor: 7.397

6.  Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.

Authors:  Daniel M Andrews; Lucy C Sullivan; Nikola Baschuk; Christopher J Chan; Richard Berry; Claire L Cotterell; Jie Lin; Heloise Halse; Sally V Watt; Jennifer Poursine-Laurent; Chyung-Ru Wang; Anthony A Scalzo; Wayne M Yokoyama; Jamie Rossjohn; Andrew G Brooks; Mark J Smyth
Journal:  Nat Immunol       Date:  2012-11-11       Impact factor: 25.606

7.  Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.

Authors:  Yan Gan; Ruolan Liu; Wei Wu; Roberto Bomprezzi; Fu-Dong Shi
Journal:  J Neuroimmunol       Date:  2012-04-13       Impact factor: 3.478

Review 8.  Natural killer cell receptors and their ligands in liver diseases.

Authors:  Satoshi Yamagiwa; Hiroteru Kamimura; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2009-03-18       Impact factor: 2.309

9.  Altered gene expression and function of peripheral blood natural killer cells in children with autism.

Authors:  Amanda M Enstrom; Lisa Lit; Charity E Onore; Jeff P Gregg; Robin L Hansen; Isaac N Pessah; Irva Hertz-Picciotto; Judy A Van de Water; Frank R Sharp; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2008-08-14       Impact factor: 7.217

10.  Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway.

Authors:  J A Graham; R A Wilkinson; T Hirohashi; C M Chase; R B Colvin; J C Madsen; J A Fishman; P S Russell
Journal:  Am J Transplant       Date:  2009-11       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.